Abstract:Introduction: This study aimed to evaluate the feasibility of using general Raman spectroscopy as a method to screen for breast cancer. The objective was to develop a machine learning model that utilizes Raman spectroscopy to detect serum samples from breast cancer patients, benign cases, and healthy subjects, with puncture biopsy as the gold standard for comparison. The goal was to explore the value of Raman spectroscopy in the differential diagnosis of breast cancer, benign lesions, and healthy individuals. Methods: In this study, blood serum samples were collected from a total of 333 participants. Among them, there were 129 cases of tumors (pathologically diagnosed as breast cancer and labeled as cancer), 91 cases of benign lesions (pathologically diagnosed as benign and labeled as benign), and 113 cases of healthy controls (labeled as normal). Raman spectra of the serum samples from each group were collected. To classify the normal, benign, and cancer sample groups, principal component analysis (PCA) combined with support vector machine (SVM) was used. The SVM model was evaluated using a cross-validation method. Results: The results of the study revealed significant differences in the mean Raman spectra of the serum samples between the normal and tumor/benign groups. Although the mean Raman spectra showed slight variations between the cancer and benign groups, the SVM model achieved a remarkable prediction accuracy of up to 98% for classifying cancer, benign, and normal groups. Discussion: In conclusion, this exploratory study has demonstrated the tremendous potential of general Raman spectroscopy as a clinical adjunctive diagnostic and rapid screening tool for breast cancer.

A Feasibility Study of Early Detection of Lung Cancer by Saliva Test Using Surface Enhanced Raman Scattering

[Application of Saliva Protein Fingerprints in the Diagnosis of Oral Squamous Cell Cancer by Surface Enhanced Laser Desorption Ionization Time of Flight Mass].

New method of lung cancer detection by saliva test using surface-enhanced Raman spectroscopy.

Preliminary Study on Detection Technology of Lung Cancer Based on Surface-Enhanced Raman Spectroscopy

Data Mining Methods of Lung Cancer Diagnosis by Saliva Tests Using Surface Enhanced Raman Spectroscopy

Study on Diagnosis of Liver Cancer by Surface Enhanced Raman Spectroscopy on Human Saliva

Surface‐enhanced Raman Spectroscopy and Multivariate Analysis for the Diagnosis of Oral Squamous Cell Carcinoma

Non-invasive diagnostic test for lung cancer using biospectroscopy and variable selection techniques in saliva samples

Detection of Nasopharyngeal Carcinoma Based on Human Saliva Surface-Enhanced Raman Spectroscopy

Surface-enhanced Raman spectroscopy of saliva proteins for the noninvasive differentiation of benign and malignant breast tumors.

Surface-enhanced Raman spectroscopy (SERS) investigations of saliva for oral cancer diagnosis

Non-Invasive Detection of Nasopharyngeal Carcinoma Using Saliva Surface-Enhanced Raman Spectroscopy

Label-free diagnosis of lung cancer with tissue-slice surface-enhanced Raman spectroscopy and statistical analysis

Raman spectroscopy as a potential diagnostic tool to analyse biochemical alterations in lung cancer

Label-free Surface-Enhanced Raman Spectroscopy for Diagnosis and Analysis of Serum Samples with Different Types Lung Cancer.

Salivary Analysis Based on Surface Enhanced Raman Scattering Sensors Distinguishes Early and Advanced Gastric Cancer Patients from Healthy Persons.

Application of Surface-Enhanced Raman Spectroscopy in the Screening of Pulmonary Adenocarcinoma Nodules

Noninvasive Detection of Nasopharyngeal Carcinoma Based on Saliva Proteins Using Surface-Enhanced Raman Spectroscopy

Label-free surface-enhanced Raman spectroscopy of serum based on multivariate statistical analysis for the diagnosis and staging of lung adenocarcinoma

Saliva analysis combining membrane protein purification with surface-enhanced Raman spectroscopy for nasopharyngeal cancer detection

Application of serum Raman spectroscopy combined with classification model for rapid breast cancer screening